URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Joseph Roscoe

Concepts (267)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
31
1998
155
8.590
Why?
Antineoplastic Agents
27
1998
619
4.400
Why?
Vomiting
17
1998
115
3.720
Why?
Neoplasms
30
1998
739
3.390
Why?
Antineoplastic Combined Chemotherapy Protocols
12
1986
429
2.810
Why?
Acupressure
5
2002
16
2.810
Why?
Fatigue
15
2001
124
2.510
Why?
Breast Neoplasms
19
1986
673
2.450
Why?
Antiemetics
12
1998
56
1.950
Why?
Vomiting, Anticipatory
7
1998
21
1.730
Why?
Acupuncture Therapy
4
2002
12
1.400
Why?
Sleep Disorders
4
2002
69
1.330
Why?
Doxorubicin
7
2003
107
1.140
Why?
Middle Aged
44
1986
9837
1.140
Why?
Aged
35
1989
7269
1.040
Why?
Radiotherapy
5
2002
198
1.040
Why?
Adult
35
1986
11351
0.940
Why?
Female
47
1986
19838
0.920
Why?
Humans
65
1986
36274
0.860
Why?
Depression
5
2001
432
0.850
Why?
Attitude
2
2000
67
0.830
Why?
Cisplatin
3
2000
95
0.790
Why?
Sleep
1
2011
59
0.770
Why?
Carboplatin
2
2003
30
0.720
Why?
Quality of Life
12
1998
502
0.700
Why?
Cyclohexanecarboxylic Acids
3
2003
48
0.680
Why?
Amines
3
2003
65
0.680
Why?
Wrist
3
2002
50
0.680
Why?
Cerebral Cortex
1
2011
248
0.680
Why?
gamma-Aminobutyric Acid
3
2003
98
0.660
Why?
Paroxetine
2
2003
11
0.630
Why?
Hot Flashes
2
2004
28
0.590
Why?
Fatigue Syndrome, Chronic
1
2007
10
0.580
Why?
Acetates
2
2003
64
0.570
Why?
Patient Education as Topic
6
2000
214
0.560
Why?
Serotonin Antagonists
4
1998
20
0.560
Why?
Psychophysiology
1
2006
15
0.550
Why?
Community Health Centers
2
2000
26
0.550
Why?
Aged, 80 and over
17
1989
2529
0.530
Why?
Male
31
1989
19675
0.530
Why?
Prochlorperazine
3
2005
11
0.530
Why?
Transcutaneous Electric Nerve Stimulation
1
2005
8
0.520
Why?
Therapeutic Touch
1
2005
3
0.520
Why?
Antidepressive Agents, Second-Generation
1
2005
14
0.510
Why?
Treatment Outcome
14
1998
2615
0.500
Why?
Behavior
1
2004
54
0.480
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.470
Why?
Physical Stimulation
1
2003
53
0.460
Why?
Tamoxifen
1
2004
81
0.450
Why?
Academic Medical Centers
2
2003
90
0.450
Why?
Radiation Injuries
1
2005
131
0.450
Why?
Double-Blind Method
7
2003
992
0.440
Why?
Behavior Therapy
4
1998
98
0.440
Why?
Electroacupuncture
1
2002
2
0.430
Why?
Benzhydryl Compounds
3
2005
13
0.390
Why?
Outcome Assessment (Health Care)
1
2003
301
0.370
Why?
Health Knowledge, Attitudes, Practice
3
2000
267
0.370
Why?
Severity of Illness Index
6
2000
922
0.320
Why?
Questionnaires
8
2000
1004
0.320
Why?
Complementary Therapies
2
2006
36
0.320
Why?
Continental Population Groups
2
1997
121
0.320
Why?
Peritoneum
1
1997
13
0.310
Why?
Urea
1
1997
53
0.300
Why?
Peritoneal Dialysis
1
1997
20
0.300
Why?
Kidney Failure, Chronic
2
1997
122
0.300
Why?
Granisetron
2
1998
7
0.300
Why?
Adaptation, Psychological
2
2006
205
0.290
Why?
Perception
3
2004
65
0.280
Why?
Patient Satisfaction
3
2004
226
0.270
Why?
Ondansetron
2
1998
11
0.240
Why?
Risk Factors
3
2000
2345
0.230
Why?
Drug Administration Schedule
3
1989
366
0.230
Why?
Dexamethasone
2
2005
181
0.230
Why?
Relaxation Therapy
2
2007
16
0.220
Why?
Activities of Daily Living
2
2001
261
0.220
Why?
Age Factors
4
2004
1128
0.220
Why?
Quinuclidines
1
2012
5
0.220
Why?
Receptors, Neurokinin-1
1
2012
7
0.220
Why?
Intention to Treat Analysis
1
2012
9
0.220
Why?
Pain
2
2006
382
0.210
Why?
Morpholines
1
2012
41
0.210
Why?
Isoquinolines
1
2012
61
0.210
Why?
Professional Role
1
2012
22
0.210
Why?
Polysomnography
1
2011
23
0.200
Why?
Oral Health
1
2012
41
0.200
Why?
Ginger
1
2011
5
0.200
Why?
Mouth Diseases
1
2012
46
0.200
Why?
Phytotherapy
1
2011
18
0.200
Why?
Drug Therapy, Combination
1
2012
382
0.200
Why?
Psychology, Medical
1
2011
2
0.200
Why?
Cyclophosphamide
3
2003
174
0.190
Why?
Suggestion
1
2010
7
0.190
Why?
Benzodiazepines
1
2010
26
0.190
Why?
Self Efficacy
1
2011
46
0.190
Why?
Conditioning, Classical
1
2010
35
0.190
Why?
Receptors, Serotonin, 5-HT3
3
1998
8
0.180
Why?
Dentate Gyrus
1
2010
26
0.180
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Clinical Trials as Topic
4
1989
671
0.180
Why?
Serotonin 5-HT3 Receptor Antagonists
2
2004
7
0.180
Why?
Information Seeking Behavior
1
2009
3
0.170
Why?
Pilot Projects
3
2004
442
0.170
Why?
Hypnosis
2
2006
16
0.170
Why?
Information Services
1
2009
22
0.170
Why?
Diabetes Mellitus, Type 2
1
2012
224
0.170
Why?
Community Health Services
2
2006
77
0.170
Why?
Insulin-Like Growth Factor I
1
2010
104
0.170
Why?
Blood-Brain Barrier
1
2010
108
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.170
Why?
Placebos
2
2005
178
0.170
Why?
Adolescent
6
1989
4766
0.170
Why?
Gene Expression Regulation, Neoplastic
1
2011
256
0.160
Why?
Awareness
1
2008
34
0.160
Why?
Pregnancy
2
2002
1966
0.160
Why?
Cognition Disorders
1
2011
286
0.150
Why?
Sickness Impact Profile
1
2007
41
0.150
Why?
Young Adult
2
2009
1059
0.150
Why?
Stress, Psychological
1
2011
285
0.150
Why?
Survivors
2
2004
118
0.150
Why?
Cognition
1
2009
227
0.140
Why?
Incidence
1
2009
685
0.140
Why?
Administration, Oral
2
2003
308
0.140
Why?
Placebo Effect
1
2006
35
0.140
Why?
Acupuncture Points
1
2005
2
0.130
Why?
Serotonin
2
2001
101
0.130
Why?
Choice Behavior
1
2006
46
0.130
Why?
Models, Psychological
1
2006
88
0.130
Why?
Menopause
1
2005
43
0.130
Why?
Motion Sickness
1
2004
8
0.130
Why?
Sex Factors
3
1997
597
0.130
Why?
Tai Ji
1
2004
22
0.120
Why?
Chronic Disease
1
2007
522
0.120
Why?
Exercise
1
2006
182
0.120
Why?
Analysis of Variance
4
2003
736
0.120
Why?
Decision Making
1
2006
223
0.120
Why?
Serotonin Uptake Inhibitors
1
2003
34
0.120
Why?
Combined Modality Therapy
1
2005
486
0.110
Why?
Demography
3
2006
101
0.110
Why?
Receptors, Serotonin
2
1998
12
0.110
Why?
New England
1
2002
24
0.110
Why?
Pregnancy Complications
1
2004
198
0.110
Why?
Cross-Over Studies
1
2002
128
0.100
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2001
6
0.100
Why?
Affect
1
2001
74
0.100
Why?
Health Surveys
3
2004
215
0.100
Why?
Patients
1
2001
45
0.100
Why?
Circadian Rhythm
1
2001
84
0.100
Why?
Reference Values
1
2002
439
0.100
Why?
Time Factors
5
1986
3182
0.090
Why?
Multivariate Analysis
1
2002
541
0.090
Why?
Ovarian Neoplasms
1
2000
106
0.080
Why?
Self-Assessment
2
2006
52
0.080
Why?
Regression Analysis
1
2000
527
0.080
Why?
Follow-Up Studies
4
1989
1855
0.080
Why?
Diabetic Nephropathies
1
1997
23
0.080
Why?
Permeability
1
1997
80
0.080
Why?
Asian Continental Ancestry Group
1
1997
30
0.070
Why?
Carcinoma
1
1999
191
0.070
Why?
Patient Acceptance of Health Care
2
2008
110
0.070
Why?
Weight Loss
2
2004
74
0.070
Why?
Animals
2
2010
16093
0.070
Why?
Biological Transport
1
1997
381
0.070
Why?
African Continental Ancestry Group
1
1997
125
0.070
Why?
Prostatic Neoplasms
1
2002
555
0.070
Why?
Palliative Care
1
1998
159
0.070
Why?
Social Support
2
2004
227
0.070
Why?
Ethnic Groups
1
1997
152
0.070
Why?
Physician-Patient Relations
3
2000
359
0.070
Why?
Longitudinal Studies
2
2005
395
0.070
Why?
United States
3
2006
2688
0.070
Why?
European Continental Ancestry Group
1
1997
234
0.070
Why?
Attitude to Health
2
2006
208
0.060
Why?
Prevalence
2
2002
562
0.060
Why?
Dose-Response Relationship, Drug
2
2001
1117
0.060
Why?
General Practice
1
2012
1
0.050
Why?
Directive Counseling
1
2012
5
0.050
Why?
New York
2
2006
1305
0.050
Why?
Patient Preference
1
2012
9
0.050
Why?
Dentistry
1
2012
19
0.050
Why?
Qualitative Research
1
2012
53
0.050
Why?
Self Care
1
2012
58
0.050
Why?
Indiana
1
2011
6
0.050
Why?
Massage
1
2011
9
0.050
Why?
Interviews as Topic
1
2012
177
0.050
Why?
Factor Analysis, Statistical
1
2011
57
0.050
Why?
Interleukin-8
1
2011
111
0.050
Why?
Patient Care Team
1
2012
192
0.050
Why?
Energy Metabolism
1
2011
137
0.050
Why?
Bromodeoxyuridine
1
2010
66
0.050
Why?
Neurogenesis
1
2010
29
0.050
Why?
Chemokine CCL2
1
2011
127
0.040
Why?
Fluorouracil
1
2010
78
0.040
Why?
Paclitaxel
1
2010
58
0.040
Why?
Psychometrics
1
2011
223
0.040
Why?
Outpatients
1
2009
33
0.040
Why?
Glomerulonephritis, Membranous
1
1989
2
0.040
Why?
Confidence Intervals
1
2009
165
0.040
Why?
Memory
1
2009
102
0.040
Why?
Interleukin-6
1
2011
339
0.040
Why?
Health Behavior
1
2009
101
0.040
Why?
Needs Assessment
1
2009
95
0.040
Why?
Prednisone
1
1989
165
0.040
Why?
Health Services Needs and Demand
1
2009
103
0.040
Why?
Odds Ratio
1
2009
315
0.040
Why?
National Cancer Institute (U.S.)
1
2007
12
0.040
Why?
Attention
1
2009
149
0.040
Why?
Reproducibility of Results
1
2011
877
0.040
Why?
Quality Indicators, Health Care
1
2007
55
0.040
Why?
Cognitive Therapy
1
2007
40
0.040
Why?
Sulfinpyrazone
1
1986
2
0.040
Why?
Argininosuccinic Acid
1
1986
3
0.040
Why?
Mitomycins
1
1986
17
0.040
Why?
Plasmapheresis
1
1986
26
0.030
Why?
National Institutes of Health (U.S.)
1
2006
63
0.030
Why?
Cancer Care Facilities
1
2006
11
0.030
Why?
Cell Proliferation
1
2010
515
0.030
Why?
Arginine
1
1986
108
0.030
Why?
Radiotherapy, Adjuvant
1
2006
73
0.030
Why?
Chemotherapy, Adjuvant
1
2006
88
0.030
Why?
Program Evaluation
1
2006
206
0.030
Why?
Electric Stimulation Therapy
1
2005
29
0.030
Why?
Radiation Dosage
1
2005
125
0.030
Why?
Alopecia
1
2004
21
0.030
Why?
Mice, Inbred C57BL
1
2010
1675
0.030
Why?
Antidepressive Agents
1
2005
93
0.030
Why?
Psychotherapy
1
2005
87
0.030
Why?
Acute Disease
1
2005
586
0.030
Why?
Self Concept
1
2004
102
0.030
Why?
Educational Status
1
2004
177
0.030
Why?
Glucocorticoids
1
2005
162
0.030
Why?
Blood Platelets
1
1986
277
0.030
Why?
Randomized Controlled Trials as Topic
1
2005
411
0.030
Why?
Communication
1
2006
273
0.030
Why?
Psychiatric Status Rating Scales
1
2003
334
0.030
Why?
Chi-Square Distribution
1
2003
344
0.030
Why?
Neurons
1
2010
1083
0.030
Why?
Hospitals, Chronic Disease
1
2001
2
0.030
Why?
Ontario
1
2001
11
0.030
Why?
Behavioral Medicine
1
2001
10
0.030
Why?
Peritonitis
1
2001
34
0.030
Why?
Infection
1
2001
66
0.020
Why?
Health Status Indicators
1
2002
107
0.020
Why?
Vagus Nerve
1
2001
40
0.020
Why?
Pituitary-Adrenal System
1
2001
35
0.020
Why?
Autonomic Nervous System
1
2001
68
0.020
Why?
Hypothalamo-Hypophyseal System
1
2001
54
0.020
Why?
Catheters, Indwelling
1
2001
70
0.020
Why?
Anemia
1
2001
78
0.020
Why?
Sampling Studies
1
2000
48
0.020
Why?
Professional-Patient Relations
1
2000
44
0.020
Why?
Breast Neoplasms, Male
1
1999
6
0.020
Why?
Informed Consent
1
2000
84
0.020
Why?
Adenosine Triphosphate
1
2001
404
0.020
Why?
Data Collection
1
2000
215
0.020
Why?
Mice
1
2010
6111
0.020
Why?
Emetics
1
1998
4
0.020
Why?
Cytokines
1
2001
565
0.020
Why?
Creatinine
2
1986
127
0.020
Why?
Sensitivity and Specificity
1
2000
905
0.020
Why?
Retrospective Studies
1
2001
2267
0.020
Why?
Proteinuria
1
1989
29
0.010
Why?
Random Allocation
1
1989
248
0.010
Why?
Tablets, Enteric-Coated
1
1986
2
0.010
Why?
Dipyridamole
1
1986
9
0.010
Why?
Mitomycin
1
1986
18
0.010
Why?
Prospective Studies
1
1989
1689
0.010
Why?
Adenocarcinoma
1
1986
439
0.010
Why?

Visualizations


Roscoe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department